Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumor.

Authors

null

Stephanie Anne Holler Howard

Dana-Farber Cancer Institute, Boston, MA

Stephanie Anne Holler Howard , Kathryn P. Gray , Elizabeth O'Donnell , Fiona M. Fennessy , Clair Beard , Christopher Sweeney

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Penile, Urethral, and Testicular Cancers

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 363)

DOI

10.1200/jco.2014.32.4_suppl.363

Abstract #

363

Poster Bd #

C6

Abstract Disclosures

Similar Posters

Poster

2014 Genitourinary Cancers Symposium

<span>Stage I testicular tumor: How frequently to scan?</span>

Stage I testicular tumor: How frequently to scan?

First Author: Sindhu Ramamurthy

Poster

2024 ASCO Genitourinary Cancers Symposium

<span>Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.</span>

Association of DAZL expression with risk of recurrence in clinical stage 1 testicular germ cell tumors.

First Author: Alok Tewari

Poster

2024 ASCO Genitourinary Cancers Symposium

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

First Author: Antoine Morin Coulombe

First Author: Thomas Wagner